Use of pancreatic colipase antagonists to impede weight gain

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/00 (2006.01) A61K 45/00 (2006.01) C07K 16/02 (2006.01) C07K 16/40 (2006.01)

Patent

CA 2484088

A therapy for humans or other animals is described using one or more antagonists to colipase so as to interfere with macromolecular nutrient digestion. In one embodiment, the present invention describes the use of antibodies that can be administered by a variety of routes, including orally, over a treatment period in a manner that promotes weight loss or impedes weight gain.

L'invention porte sur une thérapie s'appliquant à l'homme et aux animaux utilisant un ou plusieurs antagonistes de la colipase influant sur la digestion des nutriments macromoléculaires. Dans une exécution l'invention porte sur l'utilisation d'anticorps administrables de différentes manières, dont la voie orale, pendant la durée d'un traitement pour favoriser la perte de poids ou empêcher la prise de poids.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of pancreatic colipase antagonists to impede weight gain does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of pancreatic colipase antagonists to impede weight gain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of pancreatic colipase antagonists to impede weight gain will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1685725

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.